# Taurine intake ameliorates lactic acidosis and hyperferritinemia occurring after mRNA SARS-CoV-2 vaccination in a patient with β-thalassemia trait: a case report and review of literature

**Authors:** Anthony M. Kyriakopoulos, Peter A. McCullough, Stephanie Seneff

PMC · DOI: 10.1186/s13256-026-05844-z · 2026-01-28

## TL;DR

A patient with β-thalassemia trait experienced lactic acidosis and high ferritin after an mRNA vaccine, but taurine intake helped manage these symptoms.

## Contribution

This case report suggests taurine may mitigate post-vaccination complications in β-thalassemia patients.

## Key findings

- Taurine intake reduced lactate levels and prevented lactic acidosis in a β-thalassemia patient.
- Taurine helped lower hyperferritinemia following mRNA vaccination.
- Taurine may protect mitochondrial function in patients with β-thalassemia trait.

## Abstract

Taurine is a powerful antioxidant necessary for mitochondrial function. Lactic acidosis is a complication encountered in the condition mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), which can be successfully treated with supplemental taurine. Furthermore, taurine regulates the production of iron-dependent proteins such as ferritin that can act as chelating agents to sequester labile iron.

A 38-year-old Greek male with a β-zero thalassemia trait developed multiple severe symptoms soon after his first and only mRNA (Pfizer) SARS-CoV-2 vaccination that included hematological stress to be a candidate for blood transfusion. Amongst the hematological readings, the patient had lactate levels > 4 mmol/ml, indicating lactic acidosis, and ferritin levels > 820 ng/ml, representing hyperferritinemia. Moreover, the patient has organic acid and plasma metabolite levels in the urine that are indicative of mitochondrial dysfunction. Regular taurine intake (500 mg/day) for years helped the patient control lactate and ferritin levels and avoid more serious clinical decompensation.

Regular taurine intake helps to avoid lactic acidosis and reverse hyperferritinemia after mRNA SARS-CoV-2 vaccination in a patient with β-zero thalassemia trait with no obvious genetic trait linked to mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Taurine seemed to be protective for mitochondria.

## Linked entities

- **Proteins:** ferritin (soma ferritin-like)
- **Chemicals:** taurine (PubChem CID 1123), lactic acid (PubChem CID 612)
- **Diseases:** MELAS (MONDO:0010789), hyperferritinemia (MONDO:0958237), lactic acidosis (MONDO:0006040)

## Full-text entities

- **Diseases:** encephalopathy (MESH:D001927), mitochondrial myopathy (MESH:D017240), Lactic acidosis (MESH:D000140), hyperferritinemia (MESH:D000085583), mitochondrial dysfunction (MESH:D028361), stroke-like (MESH:D020521), beta-thalassemia (MESH:D017086)
- **Chemicals:** Taurine (MESH:D013654), organic acid (-), iron (MESH:D007501), lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

---
Source: https://tomesphere.com/paper/PMC12924328